ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN

被引:0
|
作者
Saga, Yosuke [1 ]
Horio, Hiroshi [1 ]
Chiang, Chih-Lin [1 ]
Wakamatsu, Akihide [1 ]
机构
[1] Janssen Pharm KK, Med Affairs Div, Tokyo, Japan
关键词
antipsychotic; extrapyramidal symptoms; tardive dyskinesia; database study; reporting odds ratio;
D O I
10.1093/ijnp/pyae059.047
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
pyae059.04
引用
收藏
页码:i26 / i27
页数:2
相关论文
共 50 条
  • [31] AN ELECTROENCEPHALOGRAPHIC STUDY OF PSYCHIATRIC-INPATIENTS WITH ANTIPSYCHOTIC-INDUCED TARDIVE-DYSKINESIA
    KOSHINO, Y
    HIRAMATSU, H
    ISAKI, K
    YAMAGUCHI, N
    CLINICAL ELECTROENCEPHALOGRAPHY, 1986, 17 (01): : 30 - 35
  • [32] Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?
    Chan, Lai Fong
    Zai, Clement
    Monda, Marcellino
    Potkin, Steven
    Kennedy, James L.
    Remington, Gary
    Lieberman, Jeffrey
    Meltzer, Herbert Y.
    De Luca, Vincenzo
    PHARMACOGENOMICS, 2013, 14 (11) : 1273 - 1281
  • [33] Anticholinergics to treat antipsychotic-induced extrapyramidal symptoms: Time to avoid this practice
    Koola, Maju Mathew
    ASIAN JOURNAL OF PSYCHIATRY, 2018, 31 : 100 - 101
  • [34] Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice
    Hauser, Robert A.
    Meyer, Jonathan M.
    Factor, Stewart A.
    Comella, Cynthia L.
    Tanner, Caroline M.
    Xavier, Rose Mary
    Caroff, Stanley N.
    Lundt, Leslie
    CNS SPECTRUMS, 2022, 27 (02) : 208 - 217
  • [35] There has been very little progress in treating or preventing antipsychotic-induced tardive dyskinesia
    van Harten, Peter
    EVIDENCE-BASED MENTAL HEALTH, 2018, 21 (03) : E10 - +
  • [36] PHOSPHODIESTERASE 4B GENETIC VARIANTS ARE NOT ASSOCIATED WITH ANTIPSYCHOTIC-INDUCED TARDIVE DYSKINESIA
    Souza, Renan P.
    Remington, Gary
    Meltzer, Herbert Y.
    Lieberman, Jeffrey A.
    Kennedy, James L.
    Wong, Albert H.
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 339 - 339
  • [37] Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder
    Wu, Wei-Yi
    Chan, Hung-Yu
    Tan, Happy Kuy-Lok
    ACTA NEUROPSYCHIATRICA, 2014, 26 (01): : 61 - 64
  • [38] Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia
    Souza, Renan P.
    Remington, Gary
    Meltzer, Herbert Y.
    Lieberman, Jeffrey A.
    Kennedy, James L.
    Wong, Albert H. C.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (05) : 264 - 269
  • [39] Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility
    Kasten, Meike
    Brueggemann, Norbert
    Koenig, Inke R.
    Doerry, Katja
    Steinlechner, Susanne
    Wenzel, Liv
    Lohmann, Katja
    Klein, Christine
    Lencer, Rebekka
    PSYCHOPHARMACOLOGY, 2011, 214 (03) : 729 - 736
  • [40] A disproportionality analysis of antipsychotic-induced hyperprolactinemia based on FDA adverse event reporting system
    Song, Min
    Li, Dong
    Peng, Jing
    Wang, Na
    Zhang, Mei
    Ren, Xiao-Lei
    Sun, Hai-Ling
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (12) : 543 - 552